Bristol Myers Squibb EBITDA 2010-2024 | BMY

Bristol Myers Squibb EBITDA for the quarter ending September 30, 2024 was $3.882B, a 9.53% decline year-over-year.

  • Bristol Myers Squibb 2023 EBITDA was 18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 EBITDA was 17.989B, a 4.23% decline from 2021.
  • Bristol Myers Squibb 2021 EBITDA was 18.784B, a 435.31% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bristol Myers Squibb EBITDA 2010-2024 | BMY

  • Bristol Myers Squibb 2023 EBITDA was 18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 EBITDA was 17.989B, a 4.23% decline from 2021.
  • Bristol Myers Squibb 2021 EBITDA was 18.784B, a 435.31% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.